| Code | 9763D | ||||||||||
| MA number | 18/0048/22-S | ||||||||||
| Product Form: | tbl flm 30x50 mg/850 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | TEVA Pharmaceuticals Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 14.03.2022 |
| Validity: | 14.03.2027 |
| SPC: |
SPC_Sitagliptin_Metformin Teva_09.2024.pdf
|
| PIL: |
PIL_Sitagliptin_Metformin Teva_09.2024.pdf
|
| Safety feature | Yes |
| Data update: | 12.04.2024 |
